Literature DB >> 8523566

Identification of a minimal hydrophobic domain in the herpes simplex virus type 1 scaffolding protein which is required for interaction with the major capsid protein.

Z Hong1, M Beaudet-Miller, J Durkin, R Zhang, A D Kwong.   

Abstract

Recent biochemical and genetic studies have demonstrated that an essential step of the herpes simplex virus type 1 capsid assembly pathway involves the interaction of the major capsid protein (VP5) with either the C terminus of the scaffolding protein (VP22a, ICP35) or that of the protease (Pra, product of UL26). To better understand the nature of the interaction and to further map the sequence motif, we expressed the C-terminal 30-amino-acid peptide of ICP35 in Escherichia coli as a glutathione S-transferase fusion protein (GST/CT). Purified GST/CT fusion proteins were then incubated with 35S-labeled herpes simplex virus type 1-infected cell lysates containing VP5. The interaction between GST/CT and VP5 was determined by coprecipitation of the two proteins with glutathione Sepharose beads. Our results revealed that the GST/CT fusion protein specifically interacts with VP5, suggesting that the C-terminal domain alone is sufficient for interaction with VP5. Deletion analysis of the GST/CT binding domain mapped the interaction to a minimal 12-amino-acid motif. Substitution mutations further revealed that the replacement of hydrophobic residues with charged residues in the core region of the motif abolished the interaction, suggesting that the interaction is a hydrophobic one. A chaotropic detergent, 0.1% Nonidet P-40, also abolished the interaction, further supporting the hydrophobic nature of the interaction. Computer analysis predicted that the minimal binding motif could form a strong alpha-helix structure. Most interestingly, the alpha-helix model maximizes the hydropathicity of the minimal domain so that all of the hydrophobic residues are centered around a Phe residue on one side of the alpha-helix. Mutation analysis revealed that the Phe residue is absolutely critical for the binding, since changes to Ala, Tyr, or Trp abrogated the interaction. Finally, in a peptide competition experiment, the C-terminal 25-amino-acid peptide, as well as a minimal peptide derived from the binding motif, competed with GST/CT for interaction with VP5. In addition, a cyclic analog of the minimal peptide which is designed to stabilize an alpha-helical structure competed more efficiently than the minimal peptide. The evidence suggests that the C-terminal end of ICP35 forms an alpha-helical secondary structure, which may bind specifically to a hydrophobic pocket in VP5.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8523566      PMCID: PMC189841     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Characterization of three species of nucleocapsids of equine herpesvirus type-1 (EHV-1).

Authors:  M L Perdue; J C Cohen; M C Kemp; C C Randall; D J O'Callaghan
Journal:  Virology       Date:  1975-03       Impact factor: 3.616

2.  Identification of genes encoding two capsid proteins (VP24 and VP26) of herpes simplex virus type 1.

Authors:  M D Davison; F J Rixon; A J Davison
Journal:  J Gen Virol       Date:  1992-10       Impact factor: 3.891

3.  The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth.

Authors:  M Gao; L Matusick-Kumar; W Hurlburt; S F DiTusa; W W Newcomb; J C Brown; P J McCann; I Deckman; R J Colonno
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

4.  Characterization of the protease and other products of amino-terminus-proximal cleavage of the herpes simplex virus 1 UL26 protein.

Authors:  F Liu; B Roizman
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

5.  Characterization of the Epstein-Barr virus proteinase and comparison with the human cytomegalovirus proteinase.

Authors:  G Donaghy; R Jupp
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

6.  The herpes simplex virus gene UL26 proteinase in the presence of the UL26.5 gene product promotes the formation of scaffold-like structures.

Authors:  V G Preston; M F al-Kobaisi; I M McDougall; F J Rixon
Journal:  J Gen Virol       Date:  1994-09       Impact factor: 3.891

7.  Identification and characterization of a herpes simplex virus gene product required for encapsidation of virus DNA.

Authors:  V G Preston; J A Coates; F J Rixon
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

8.  Herpes simplex virus type 1 capsid protein, VP21, originates within the UL26 open reading frame.

Authors:  S Person; S Laquerre; P Desai; J Hempel
Journal:  J Gen Virol       Date:  1993-10       Impact factor: 3.891

9.  Localization of the herpes simplex virus type 1 major capsid protein VP5 to the cell nucleus requires the abundant scaffolding protein VP22a.

Authors:  P Nicholson; C Addison; A M Cross; J Kennard; V G Preston; F J Rixon
Journal:  J Gen Virol       Date:  1994-05       Impact factor: 3.891

10.  Distinct monoclonal antibodies separately label the hexons or the pentons of herpes simplex virus capsid.

Authors:  B L Trus; W W Newcomb; F P Booy; J C Brown; A C Steven
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

View more
  41 in total

1.  Roles of triplex and scaffolding proteins in herpes simplex virus type 1 capsid formation suggested by structures of recombinant particles.

Authors:  A Saad; Z H Zhou; J Jakana; W Chiu; F J Rixon
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 2.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

3.  pH reduction as a trigger for dissociation of herpes simplex virus type 1 scaffolds.

Authors:  David A McClelland; James D Aitken; David Bhella; David McNab; Joyce Mitchell; Sharon M Kelly; Nicholas C Price; Frazer J Rixon
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

4.  Mutation of single hydrophobic residue I27, L35, F39, L58, L65, L67, or L71 in the N terminus of VP5 abolishes interaction with the scaffold protein and prevents closure of herpes simplex virus type 1 capsid shells.

Authors:  Jewell N Walters; Gerry L Sexton; J Michael McCaffery; Prashant Desai
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

5.  Identification of a region in the herpes simplex virus scaffolding protein required for interaction with the portal.

Authors:  Gregory P Singer; William W Newcomb; Darrel R Thomsen; Fred L Homa; Jay C Brown
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  Cleavage of human cytomegalovirus protease pUL80a at internal and cryptic sites is not essential but enhances infectivity.

Authors:  Amy N Loveland; Chee-Kai Chan; Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Proline and tyrosine residues in scaffold proteins of herpes simplex virus 1 critical to the interaction with portal protein and its incorporation into capsids.

Authors:  Kui Yang; Joel D Baines
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

8.  Regions of the herpes simplex virus scaffolding protein that are important for intermolecular self-interaction.

Authors:  Valerie G Preston; Iris M McDougall
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

9.  Cytomegalovirus assembly protein precursor and proteinase precursor contain two nuclear localization signals that mediate their own nuclear translocation and that of the major capsid protein.

Authors:  S M Plafker; W Gibson
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

10.  Capsid structure of simian cytomegalovirus from cryoelectron microscopy: evidence for tegument attachment sites.

Authors:  B L Trus; W Gibson; N Cheng; A C Steven
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.